Delivery Order SPE2DE24D0013-SPE2D625F87KB

Award Date 2/20/25
Potential Completion Date 2/27/25
Potential Value $6.8K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical conditions. The contract has a ceiling value of $2,720.00 and is a firm fixed-price delivery order...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract, valued at $5,440.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $2,244.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The products are intended to support the detection of infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, involves the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), Methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. The $40,800.00 firm fixed-price delivery order contract was awarded by the Defense Logistics...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and others. The contract, valued at $2,040.00, is a firm fixed-price delivery order placed by the Defense Logistics Agency, a defense agency. The contract does not have a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $5,440.00 firm fixed-price delivery order contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has no set-aside designation. Cepheid holds several significant...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $2,040.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is not...
This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has an award value of $5,440.00 and is a firm fixed-price delivery order. Cepheid will provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, reagents, and test kits, to support the detection of infectious diseases such as COVID-19, influenza, and respiratory...
This is a federal contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $6,800.00, is a delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other conditions. The contract is a...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $4,080.00, is a firm fixed-price delivery order that provides the DLA with Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These products and services are used for detecting a variety of infectious diseases, including COVID-19, influenza, and respiratory...
  • SPE2DE24D0013
    Indefinite Delivery Contract
  • SPE2DE24D0013-SPE2D625F87KB
    Delivery Order

This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) to provide GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract is a $6,800.00 firm fixed-price delivery order with a period of performance through February 27, 2025. Cepheid has several significant federal contract Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and Indian Health Service, enabling these agencies to continuously procure Cepheid's molecular diagnostic solutions. The contract does not have a set-aside designation.

Generated 5/22/25, 8:25 PM